SCOPUS 정보 검색 플랫폼

Volumn 71, Issue 2, 2002, Pages 95-102

Factors associated with success of the extreme drug resistance assay in primary breast cancer specimens

(13) Ellis, Robert J a Fabian, Carol J a Kimler, Bruce F b Tawfik, Ossama c Mayo, Matthew S d Decelis, Carlos Rubin a Jewell, William R e Connor, Carol e Modrell, Carol b Praeger, Mark f McGinness, Marilee f Mehta, Rita g Fruehauf, John P g

a Division of Oncology (United States)

b Department of Radiation Oncology ^* (United States)

c Laboratory Medicine (United States)

d Kansas City Cancer Centers (United States)

e UNIVERSITY OF KANSAS MEDICAL CENTER (United States)

f Lawrence Memorial Hospital (United States)

g UNIVERSITY OF CALIFORNIA (United States)

Author keywords

Biomarker; Chemotherapy; Correlation; Extreme drug resistance; Prediction; Primary breast cancer; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; MITOMYCIN C; MITOXANTRONE; NAVELBINE; PACLITAXEL; PROGESTERONE RECEPTOR; VINBLASTINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RESISTANCE; DISEASE ASSOCIATION; FEASIBILITY STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE NEU; PRIORITY JOURNAL; TUMOR CELL CULTURE;

AGE FACTORS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL SURVIVAL; COHORT STUDIES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; TUMOR CELLS, CULTURED;

EID: 0036169789 PISSN: 01676806 EISSN: None Source Type: Journal
DOI: 10.1023/A:1013843912560 Document Type: Article

Times cited : (9)

References (33)

1
- 0025230399
- Highly specific prediction of anti-neoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures
- (1990) J Natl Cancer Inst , vol.82 , pp. 582-588
- Kern, D.H.¹ Weisenthal, L.M.²

2
- 0032896336
- Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity for patients with cancer
- (1999) J Clin Oncol , vol.17 , pp. 1625-1631
- Cortazar, P.¹ Johnson, B.E.²

3
- 0029990074
- Tumor chemosensitivity and chemo-resistance assays
- (1997) Cancer , vol.77 , pp. 1020-1025
- Brown, E.¹ Markman, J.²

4
- 0032168380
- Correlation between extreme drug resistance assay and response to primary paclitaxel and cisplatin in patients with epithelial ovarian cancer
- (1998) Gynecol Oncol , vol.70 , pp. 392-397
- Eltabbakh, G.H.¹ Piver, M.S.² Hempling, R.E.³ Recio, F.O.⁴ Lele, S.B.⁵ Marchetti, D.L.⁶ Baker, T.R.⁷ Blumenson, L.E.⁸

5
- 0020434188
- The World Health Organization histological typing of breast rumors
- 2nd edn
- (1982) Am J Clin Pathol , vol.78 , pp. 806-816
- Azzopardi, J.G.¹ Chepick, O.F.² Hartmann, W.H.³ Jafarey, N.A.⁴ Llombart-Bosch, A.⁵ Ozzello, L.⁶ Rilke, F.⁷ Sasano, N.⁸ Sobin, L.H.⁹ Sommers, S.C.¹⁰ Stalsberg, H.¹¹ Sugar, J.¹² Williams, A.O.¹³

6
- 70449185514
- Histologic grading and prognosis in breast cancer: A study of 1709 cases of which 359 have been followed for 15 years
- (1957) Br J Cancer , vol.2 , pp. 353-377
- Bloom, H.J.G.¹ Richardson, W.W.²

7
- 0001271962
- Grading of invasive carcinoma of the breast
- Page DL, Anderson TJ (eds). Churchill Livingstone, New York
- (1987) Diagnostic Histopathology of the Breast , pp. 303
- Elston, C.W.¹

8
- 0026474087
- Estrogen and progesterone detection in archival formalin-fixed, paraffin-embedded tissue from breast carcinoma: A comparison of immunocytochemistry with dextran coated charcoal assay
- (1992) Mod Pathol , vol.5 , pp. 79-84
- Wilbur, D.C.¹ Willis, J.² Mooney, R.A.³ Fallon, R.A.⁴ Moynes, R.⁵ Di Sant' Agnese, P.A.⁶

9
- 0023683287
- The evaluation of estrogen receptor in primary breast carcinoma by computer assisted image analysis
- (1988) Am J Clin Pathol , vol.90 , pp. 233-239
- Bacus, S.S.¹ Flowers, J.L.² Press, M.F.³ Bacus, J.W.⁴ McCarty Jr., K.S.⁵

10
- 0004000068
- Immunochemical staining methods handbook
- Naish SJ, Farmilo AJ, Stead RH (eds). Dako Corporation, Carpinteria California
- (1989) Staining Methods , pp. 13-19
- Boenisch, T.¹

11
- 0000405942
- Addition of Herceptin™ (humanized anti-her2 antibody) to first line chemotherapy for her2 overexpressing metastatic breast cancer (her2+/MBC) markedly increases anticancer activity: A randomized, multinational controlled phase III trial
- abstr 377
- (1998) Proc Am Soc Clin Oncol , vol.17
- Slamon, D.J.¹ Leyland-Jones, B.² Shak, S.³ Paton, V.⁴ Bajamonde, A.⁵ Fleming, T.⁶ Eirmann, W.⁷ Wolter, J.⁸ Baselga, J.⁹ Norton, L.¹⁰

12
- 4244182270
- Association between breast cancer survival and in vitro drug response in the EDR assay
- abstr 310B
- (2000) Proc Am Soc Clin Oncol , vol.19
- Mehta, R.¹ Bornstein, R.² Yu, I.³ Parker, R.⁴ Fruehauf, J.⁵

13
- 0028177107
- Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer
- (1994) J Clin Oncol , vol.12 , pp. 888-894
- Nixon, A.J.¹ Neuberg, D.² Hayes, D.F.³ Gelman, R.⁴ Conolly, J.L.⁵ Schnitt, S.⁶ Abner, A.⁷ Recht, A.⁸ Vicini, F.⁹ Harris, J.R.¹⁰

14
- 0028707977
- Breast cancer outcome and predictors of outcome: Are there age differentials?
- (1994) J Natl Cancer Inst (Mongr) , vol.16 , pp. 35-42
- Albain, K.S.¹ Allred, D.C.² Clark, G.M.³

15
- 0022501665
- Chemosensitivities of human clonogenic breast tumor cells
- (1986) Eur J Cancer Clin Oncol , vol.22 , pp. 971-981
- Hug, V.¹ Thames, H.² Hortobagy, G.³ Finders, M.⁴

16
- 0027266775
- Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy
- (1993) J Clin Oncol , vol.11 , pp. 1150-1155
- Silvestrini, R.¹ Daidone, M.G.² Mastore, M.³ Di Fronzo, G.⁴ Coradini, D.⁵ Boracchi, P.⁶ Squicciarini, P.⁷ Salvadore, B.⁸ Veronesi, U.⁹

17
- 0027746173
- DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients
- (1993) Breast Cancer Res Treat , vol.28 , pp. 9-20
- Wenger, C.R.¹ Beardslee, S.² Owens, M.A.³ Pounds, G.⁴ Oldaker, T.⁵ Vendely, P.⁶ Pandian, M.R.⁷ Harrington, D.⁸ Clark, G.M.⁹ McGuire, W.L.¹⁰

18
- 0029878679
- The sequencing of chemotherapy and radiation therapy after conservative surgery for patients with early-stage breast cancer
- (1996) N Engl J Med , vol.334 , pp. 1356-1361
- Recht, A.¹ Come, S.E.² Henderson, I.C.³ Gelman, R.S.⁴ Silver, B.⁵ Hayes, D.F.⁶ Shulman, L.N.⁷ Harris, J.R.⁸

19
- 0008335251
- Previously treated breast cancer showed a 2-fold increased in 5FU resistance in vitro
- abstr 70
- (1992) Breast Ca Res Treat , vol.23 , pp. 148
- Fruehauf, J.P.¹ Kern, D.H.²

20
- 0008387528
- Extreme drug resistance in untreated breast cancer
- abstr 68
- (1992) Breast Cancer Res Treat , vol.23 , pp. 147
- Robert, N.J.¹ Miller, J.A.² Fruehauf, J.P.³ Kern, D.H.⁴

21
- 0001261990
- Improved disease-free (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients (pts) with node-positive primary breast cancer (BC)
- abstr 390a
- (1998) Proc Am Soc Clin Oncol , vol.17
- Henderson, I.C.¹ Berry, D.² Demetri, G.³ Cirrincione, C.⁴ Goldstein, L.⁵ Marino, S.⁶ Ingle, J.N.⁷ Cooper, M.R.⁸ Canellow, G.⁹ Borden, E.¹⁰ Fleming, F.¹¹ Holland, J.F.¹² Graziano, S.¹³ Carpenter, J.¹⁴ Muss, H.¹⁵ Norton, L.¹⁶

22
- 0029802685
- The microtubule-affecting drug paclitaxel has antiangiogenic activity
- (1996) Clin Cancer Res , vol.2 , pp. 1843-1849
- Belotti, D.¹ Vergami, V.² Drudis, T.³ Borsotti, P.⁴ Pitelli, M.R.⁵ Viale, G.⁶ Giavazzi, R.⁷ Taraboletti, G.⁸

23
- 0032930199
- Paclitaxel (Taxol): An inhibitor of angiogenesis in a highly vascularized transgenic breast cancer
- (1999) Cancer Biother Radiopharm , vol.14 , pp. 31-36
- Lau, D.H.¹ Xue, L.² Young, L.J.³ Burke, P.A.⁴ Cheung, A.T.⁵

24
- 0032412818
- The relationship between prognostic and predictive factors in the management of breast cancer
- (1998) Breast Cancer Res Treat , vol.52 , pp. 261-288
- Henderson, I.C.¹ Patek, A.J.²

25
- 0028354305
- C-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer
- (1994) N Engl J Med , vol.330 , pp. 1260-1266
- Muss, H.B.¹ Thor, A.D.² Berry, D.A.³ Kute, T.⁴ Liu, E.T.⁵ Koerner, F.⁶ Cirrincione, C.T.⁷ Budman, D.R.⁸ Wood, W.C.⁹ Barcos, M.¹⁰

26
- 0032538040
- ErbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor negative breast cancer
- (1998) J Natl Cancer Inst , vol.90 , pp. 1361-1370
- Paik, S.¹ Bryant, J.² Park, C.³ Fisher, B.⁴ Tan-Chiu, E.⁵ Hyams, D.⁶ Fisher, E.R.⁷ Lippman, M.E.⁸ Wickerham, D.L.⁹ Wolmark, N.¹⁰

27
- 0030947407
- HER2 overexpression and paclitaxel sensitivity in breast cancer: Therapeutic implications
- (1997) Oncology (Huntingt) , vol.11 , pp. 43-48
- Baselga, J.¹ Seidman, A.D.² Rosen, P.P.³ Norton, L.⁴

28
- 0000582426
- Treatment of metastatic breast cancen
- Harris JR, Lippmann ME, Morrow M, Osborne CK (eds). Lippincott Williams & Wilkins, Philadelphia, PA
- (2000) Diseases of the Breast , pp. 749-797
- Ellis, J.M.¹ Hayes, D.F.² Lippman, M.E.³

29
- 0037768158
- SEER Cancer Statistics Review: 1973-1998

30
- 0031926839
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
- (1988) J Clin Oncol , vol.16 , pp. 2672-2685
- Fisher, B.¹ Bryant, J.² Wolmark, N.³ Mamounas, E.⁴ Brown, A.⁵ Fisher, E.R.⁶ Wickerham, D.L.⁷ Begovic, M.⁸ DeCillis, A.⁹ Robidoux, A.¹⁰ Margolese, R.G.¹¹ Cruz Jr., A.B.¹² Hoehn, J.L.¹³ Lees, A.W.¹⁴ Dimitrov, N.V.¹⁵ Bear, H.D.¹⁶

31
- 0002619616
- Adjuvant chemotherapy: Taxanes. The 'pro' position
- November 1-3, Bethesda, Maryland
- (2000) Program and abstracts of the NIH Consensus Development Conference: Adjuvant Therapy for Breast Cancer
- Henderson, C.I.¹

32
- 0003294334
- NSABP B-28; initial results
- November 1-3, Bethesda, Maryland
- (2000) Program and abstracts of the NIH Consensus Development Conference: Adjuvant Therapy for Breast Cancer
- Mamounas, E.P.¹

33
- 0008295244
- Adjuvant chemotherapy: Taxanes. The 'con' position
- November 1-3, Bethesda, Maryland
- (2000) Program and abstracts of the NIH Consensus Development Conference: Adjuvant Therapy for Breast Cancer
- Piccart, M.J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.